ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 877,44
-0,02%
DAX
18 557,27
-0,48%
Brent Oil
79,585
-0,37%
Bitcoin
68 831,95
-2,73%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ocuphire Pharma Inc (OCUP)

  7. Ocuphire Pharma Inc (OCUP) Actualités

OCUP

Ocuphire Pharma (OCUP)

Ocuphire Pharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OCUP
DateHeureSourceTitreSymboleSociété
24/05/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
10/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCUPOcuphire Pharma Inc
10/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
08/03/202423h20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OCUPOcuphire Pharma Inc
16/02/202422h31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCUPOcuphire Pharma Inc
15/02/202400h32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
24/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCUPOcuphire Pharma Inc
11/01/202422h16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OCUPOcuphire Pharma Inc
10/01/202423h00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCUPOcuphire Pharma Inc
27/09/202314h00PR Newswire (US)Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., TrNASDAQ:OCUPOcuphire Pharma Inc
14/08/202314h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OCUPOcuphire Pharma Inc
14/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCUPOcuphire Pharma Inc
09/06/202300h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCUPOcuphire Pharma Inc
15/05/202314h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OCUPOcuphire Pharma Inc
01/05/202322h16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OCUPOcuphire Pharma Inc
01/05/202322h13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OCUPOcuphire Pharma Inc
05/04/202323h05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OCUPOcuphire Pharma Inc
30/03/202323h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OCUPOcuphire Pharma Inc
14/02/202320h04Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:OCUPOcuphire Pharma Inc
06/12/202222h50TipRanksAnalysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP) and Irhythm Technologies (IRTC)NASDAQ:OCUPOcuphire Pharma Inc
23/11/202222h15TipRanksJonesTrading Remains a Buy on Ocuphire Pharma (OCUP)NASDAQ:OCUPOcuphire Pharma Inc
07/11/202212h15TipRanksH.C. Wainwright Keeps Their Buy Rating on Ocuphire Pharma (OCUP)NASDAQ:OCUPOcuphire Pharma Inc
17/10/202212h25TipRanksOcuphire Pharma (OCUP) Receives a Buy from H.C. WainwrightNASDAQ:OCUPOcuphire Pharma Inc
15/08/202212h20TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:OCUPOcuphire Pharma Inc
10/06/202222h17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OCUPOcuphire Pharma Inc
22/05/202210h30TipRanksH.C. Wainwright Thinks Ocuphire Pharma’s Stock is Going to RecoverNASDAQ:OCUPOcuphire Pharma Inc
17/05/202222h38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OCUPOcuphire Pharma Inc
25/03/202211h16TipRanksOcuphire Pharma (OCUP) Gets a Buy Rating from H.C. WainwrightNASDAQ:OCUPOcuphire Pharma Inc
14/02/202222h20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OCUPOcuphire Pharma Inc
19/01/202220h45TipRanksOcuphire Pharma: A High-Risk, High-Reward StockNASDAQ:OCUPOcuphire Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OCUP

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
VK
Vallourec
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
COIN
ETHUSD
Ethereum
EU
DG
Vinci
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
EU
ML
Michelin
EU
RNO
Renault
FTSE
UKX
FTSE 100
EU
BEL20
Bel 20
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés